Please assess the completion status of the following clinical trial:

Trial Title: Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adults~* severe traumatic brain injury~* intracranial hypertension requiring mannitol administration~Exclusion Criteria:~* impeding neurosurgery~* hemodynamic or respiratory severe failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- mannitol high dose (Type: ACTIVE_COMPARATOR): mannitol 20% 0,8 g/ kg on minutes
- mannitol low dose (Type: ACTIVE_COMPARATOR): mannitol 20% 0,4 g/ kg on minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).